Stay updated on Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Sign up to get notified when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.6.4 was added to the record history, replacing the previous v3.6.3.
    Difference
    0.1%
    Check dated 2026-07-27T06:24:53.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.6.3 was added to the Record History, reflecting a site update to the ClinicalTrials.gov page. This update documents the latest version of the page without changing the study details.
    Difference
    0.1%
    Check dated 2026-07-05T14:24:15.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing the previous v3.6.0, indicating a small update to the study record presentation.
    Difference
    0.1%
    Check dated 2026-06-28T08:33:46.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The Record History now shows a new 'Last verified' label and the 'Last known status was' line, with the revision updated to v3.6.0. This replaces the prior v3.5.5 metadata.
    Difference
    3%
    Check dated 2026-06-14T07:32:03.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    ClinicalTrials.gov history now shows a new Revision: v3.5.5 entry, superseding the previous v3.5.4. This indicates an update to the study's revision history on the site.
    Difference
    0.1%
    Check dated 2026-06-07T01:17:10.000Z thumbnail image
  9. Check
    80 days ago
    Change Detected
    Summary
    A new revision entry v3.5.4 was added to the record history, replacing the previous v3.5.3 entry. This update reflects a revision history change rather than a modification to the study content.
    Difference
    0.1%
    Check dated 2026-05-16T10:34:53.000Z thumbnail image

Stay in the know with updates to Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Paclitaxel & Pyrotinib in HER2+ Breast Cancer Adjuvant Clinical Trial page.